Bayer updates label warnings for Yaz, Yasmin birth control pills


 In the wake of over 1,000 lawsuits filed by women who claim to have suffered serious injuries from the effects of birth control pills Yaz and Yasmin, German manufacturer Bayer has updated labelling information on those products regarding the risks of their use. https://askcompetentlawyer.com/ The new information, which was recently approved by the FDA in April, highlights the risk of thromboembolism (blood clots migrating through the venous or arterial system and causing occlusion) in women using Yasmin compared to those in women using oral contraceptives containing other progestins.

A progestin is a steroid hormone used to produce the effect of the female hormone progesterone. Different birth control pills may use different progestins to produce the contraceptive effect. A recent study conducted in the Netherlands, which compared the effects of a variety of oral contraceptives in a population of over 1500 women and was published in the British Medical Journal highlights an increased risk of venous thrombosis for women using all types of birth control compared to women who use no contraception, but observed a 6.3-fold increased risk of thrombosis in women using newer contraceptives composed of the fourth-generation progestin called drospirenone, which is used in Yasmin. Other contraceptives which use the earlier-generation progestin levonorgestrel noticed a smaller increase in risk (3.8-fold).

Комментарии

Популярные сообщения из этого блога

The Dangers of Making Homemade Fireworks

FDA Regulatory Authority Over Compounding Pharmacies is Unclear In Indiana, Throughout Nation

Indianapolis Explosion Still Under Investigation